Clinical Trial Update: A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy [Phase 2]

View source ↗

Summary

The document reports the completion of a Phase 2 trial in gout patients who do not respond to or are allergic to conventional therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Snippet

Sponsor: Savient Pharmaceuticals | Conditions: Gout | Phase 2 | Status: COMPLETED